샘플 요청 목록

 카트 문의
시장보고서
상품코드
1588342

뇌진탕 시장 규모, 점유율, 동향 분석 보고서 : 평가 및 치료별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Concussion Market Size, Share & Trends Analysis Report By Assessment And Treatment (Diagnosis, Treatment), By End Use (Hospitals, Diagnostic Centers) By Region, And Segment Forecasts, 2025 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

뇌진탕 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 세계 뇌진탕 시장 규모는 2025년부터 2030년까지 연평균 6.0%의 CAGR로 확대되어 2030년에는 93억 1,000만 달러에 달할 것으로 예상됩니다.

뇌진탕과 같은 관련 장애의 높은 유병률로 이어지는 뇌 손상으로 인한 부상의 수가 증가함에 따라 시장을 적극적으로 주도하고 있습니다.

낙상이나 스포츠 외상에 이어 자동차 사고가 뇌진탕 환자 입원의 주요 원인으로 꼽힙니다. 미국 질병통제예방센터(CDC)에 따르면, 매년 약 56,000명의 노인이 낙상 사고로 인한 경미한 두부 손상(뇌진탕)으로 입원하고 있습니다. 이는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.

또한, 뇌진탕과 관련된 인식을 높이기 위해 전 세계적으로 여러 가지 인식 제고 캠페인과 이니셔티브가 시행되고 있는 것도 시장 성장의 총체적인 요인으로 작용하고 있습니다. 예를 들어, Defense and Veterans Brain Injury Center는 군인과 재향 군인을 위한 최상의 치료를 촉진하기 위해 민간인과 군인 모두에게 외상성 뇌손상에 대해 배울 수 있는 온라인 교육을 제공하고 있습니다.

또한, 주요 기업들은 시장 점유율을 확대하기 위해 제휴, 신제품 출시 등 다양한 전략을 채택하고 있습니다. 이는 예측 기간 동안 시장 성장을 촉진할 것으로 보입니다. 예를 들어, 2019년 일본 코덴은 미국에서 의식을 잃은 환자의 뇌 활동을 평가하기 위한 무선 뇌파(EEG) 헤드셋을 출시했습니다.

뇌진탕 시장 보고서 하이라이트

  • 진단 분야가 2024년 72.2%의 가장 큰 매출 점유율을 차지하며 시장을 장악했습니다. 진단 분야는 진단 기술의 발전과 뇌진탕 발생률 증가로 인해 향후 몇 년 동안 크게 성장할 것으로 예상됩니다.
  • 병원 부문은 뇌진탕 관련 위험에 대한 인식이 높아지고 고급 진단 및 치료 솔루션 제공에 대한 병원의 노력으로 2024년 39.1%의 가장 큰 시장 점유율을 차지했습니다.
  • 북미 뇌진탕 시장은 2024년 매출 점유율 60.9%를 차지하며 전체 세계 시장을 장악했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 뇌진탕 시장 변수, 동향, 범위

  • 시장 계통 전망
    • 상부 시장 전망
    • 관련/부수 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 뇌진탕 시장 분석 툴
    • 업계 분석 - Porter's Five Forces 분석
    • PESTEL 분석

제4장 뇌진탕 시장 : 평가·치료 추정·동향 분석

  • 부문 대시보드
  • 뇌진탕 시장 : 평가·치료 변동 분석
  • 평가·치료별 뇌진탕 시장 전망
  • 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
  • 치료
  • 진단

제5장 뇌진탕 시장 : 최종 용도 추정·동향 분석

  • 부문 대시보드
  • 뇌진탕 시장 : 최종 용도 변동 분석
  • 최종 용도별 뇌진탕 시장 전망
  • 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
  • 병원
  • 진단 센터
  • 신경과클리닉
  • 연구 센터
  • 기타

제6장 뇌진탕 시장 : 지역 추정·동향 분석

  • 지역 대시보드
  • 시장 규모, 예측 동향 분석, 2018-2030년 :
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 노르웨이
    • 스웨덴
    • 덴마크
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 호주
    • 한국
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제7장 경쟁 상황

  • 시장 진출 기업 분류
  • 주요 시장 진출 기업의 최근 동향과 영향 분석
  • 기업 시장 점유율 분석, 2024년
  • 주요 기업 개요
    • NIHON KOHDEN CORPORATION
    • Compumedics Limited
    • INTEGRA LIFESCIENCES
    • BioDirection(NanoDx)
    • Oculogica
    • Abbott
    • BrainScope Company Inc.
    • BIOMERIEUX
    • Magstim
    • Advanced Brain Monitoring, Inc.
    • Healius Limited
ksm 24.11.25

Concussion Market Growth & Trends:

The global concussion market size is anticipated to reach USD 9.31 billion by 2030, expanding at a CAGR of 6.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing number of injuries being caused to the brain resulting in a high prevalence of associated disorders such as concussion is driving the market in a positive manner.

Falls and sports injuries followed by motor vehicle accidents are the leading causes of hospitalization in patients with concussion. As per the Centers for Disease Control and Prevention (CDC), an estimated 56,000 seniors are hospitalized every year as a result of mild head injuries (concussions) suffered due to accidental falls. This is anticipated to boost market growth over the forecast period.

In addition, several awareness campaigns and initiatives throughout the world to raise awareness related to concussion are collectively responsible for market growth. For instance, the Defense and Veterans Brain Injury Center offers online education for both civilians and military officers to learn about traumatic brain injuries in order to promote the best possible care for service members and veterans.

Furthermore, key players are adopting various strategies such as collaborations and new product launches to increase their market share. This is likely to boost market growth during the forecast period. For instance, in 2019, Nihon Kohden launched a wireless Electroencephalogram (EEG) headset in the U.S, which is intended to assess brain activity in unconscious patients.

Concussion Market Report Highlights:

  • The diagnosis segment dominated the market and accounted for the largest revenue share of 72.2% in 2024. The diagnosis segment is projected to experience substantial growth in the coming years, driven by advancements in diagnostic technologies and an increasing incidence of concussions.
  • The hospital segment accounted for the largest market share of 39.1% in 2024, driven by growing awareness of concussion-related risks and hospitals' commitment to delivering advanced diagnostic and treatment solutions.
  • The concussion market in North America dominated the overall global market and accounted for 60.9% of revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Assessment and treatment
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Concussion Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing incidence of mild traumatic brain injuries or concussions
      • 3.2.1.2. Rising number of road accidents and sports injuries
      • 3.2.1.3. Technological advancements in concussion devices
      • 3.2.1.4. Growing focus on research activities
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with concussion treatment
      • 3.2.2.2. Lack of awareness in people regarding concussion
  • 3.3. Concussion Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Concussion Market: Assessment and Treatment Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Concussion Market: Assessment and Treatment Movement Analysis
  • 4.3. Concussion Market by Assessment and Treatment Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Treatment
    • 4.5.1. Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Diagnosis
    • 4.6.1. Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Concussion Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Concussion Market: End Use Movement Analysis
  • 5.3. Concussion Market by End Use Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Hospitals
    • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Diagnostic Centers
    • 5.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Neurologic Clinics
    • 5.7.1. Neurologic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Research centers
    • 5.8.1. Neurologic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Concussion Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Recent Developments & Impact Analysis by Key Market Participants
  • 7.3. Company Market Share Analysis, 2024
  • 7.4. Key Company Profiles
    • 7.4.1. NIHON KOHDEN CORPORATION
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Compumedics Limited
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. INTEGRA LIFESCIENCES
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. BioDirection (NanoDx)
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Oculogica
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Abbott
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. BrainScope Company Inc.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. BIOMERIEUX
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Magstim
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Advanced Brain Monitoring, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Healius Limited
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제